Showing results (41-50 of 352) with videos related to
Sort By:
Pageof 36
Breathe (Sheffield, England)|October 13, 2023
Treatment-shortening regimens for tuberculosis: updates and future prioritiesFrancesca Saluzzo, Victor Abiola Adepoju, Raquel Duarte, et al.Archives of Gerontology and Geriatrics|June 12, 2012
Increased multi-drug resistance among the elderly on admission to the hospital--a 12-year surveillance studyClaudia M Denkinger, Alison D Grant, Michael Denkinger, et al.Infection|April 9, 2022
Rapid comparative evaluation of SARS-CoV-2 rapid point-of-care antigen testsAnna Denzler, Max L Jacobs, Victoria Witte, et al.BMC Infectious Diseases|September 11, 2019
Estimating the impact of a novel drug regimen for treatment of tuberculosis: a modeling analysis of projected patient outcomes and epidemiological considerationsEmily A Kendall, Shelly Malhotra, Sarah Cook-Scalise, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2019
Clinical Impact of Rapid Drug Susceptibility Testing to Accompany Fluoroquinolone-Containing Universal Tuberculosis Regimens: A Markov ModelEmily A Kendall, Shelly Malhotra, Sarah Cook-Scalise, et al.Journal of Clinical Microbiology|January 28, 2021
Performance of Saliva, Oropharyngeal Swabs, and Nasal Swabs for SARS-CoV-2 Molecular Detection: a Systematic Review and Meta-analysisRose A Lee, Joshua C Herigon, Andrea Benedetti, et al.The Lancet. Microbe|October 20, 2025
Whom tuberculosis tests detect and why it matters: implications for diagnostic algorithmsEmily A Kendall, Claudia M Denkinger, Adithya Cattamanchi, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 29, 2021
The potential of SARS-CoV-2 antigen-detection tests in the screening of asymptomatic personsJonas Wachinger, Ioana Diana Olaru, Susanne Horner, et al.Nature Microbiology|February 27, 2019
A systematic review of biomarkers to detect active tuberculosisEmily MacLean, Tobias Broger, Seda Yerlikaya, et al.The European Respiratory Journal|July 16, 2016
Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?Heidi Albert, Ruvandhi R Nathavitharana, Chris Isaacs, et al.Pageof 36